Vyant Bio (VYNT) Short Interest Ratio & Short Volume $0.19 +0.01 (+7.78%) As of 12/29/2023 Add Compare Share Share Short Interest Stock AnalysisBuy This Stock Vyant Bio Short Interest DataVyant Bio (VYNT) has a short interest of 42,600 shares. This marks a -2.29% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 161,822 shares to cover all short positions.Current Short Interest42,600 sharesPrevious Short Interest43,600 sharesChange Vs. Previous Month-2.29%Dollar Volume Sold Short$8,264.40Short Interest Ratio0.5 Days to CoverLast Record DateDecember 31, 2023Outstanding Shares6,330,000 sharesPercentage of Shares Shorted0.67%Today's Trading Volume19,100 sharesAverage Trading Volume161,822 sharesToday's Volume Vs. Average12% Short Selling Vyant Bio? Sign up to receive the latest short interest report for Vyant Bio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartVYNT Short Interest Over TimeVYNT Days to Cover Over TimeVYNT Percentage of Float Shorted Over Time Vyant Bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/31/202342,600 shares $8,264.40 -2.3%N/A0.5 $0.19 12/15/202343,600 shares $7,194.00 -23.1%N/A0.9 $0.17 11/30/202356,700 shares $10,383.19 +7.6%N/A4.4 $0.18 11/15/202352,700 shares $9,275.20 -4.2%N/A2 $0.18 10/31/202355,000 shares $9,594.20 -8.3%N/A2 $0.17 10/15/202360,000 shares $10,200.00 +11.3%N/A2.8 $0.17 9/30/202353,900 shares $9,163.00 -0.7%N/A0.8 $0.17 9/15/202354,300 shares $8,742.30 -1.1%N/A0.6 $0.16 8/31/202354,900 shares $9,058.50 -4.0%N/A0.8 $0.17 4/30/2023204,700 shares $58,892.19 +28.3%4.1%3 $0.29 Get the Latest News and Ratings for VYNT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vyant Bio and its competitors with MarketBeat's FREE daily newsletter. 4/15/2023159,500 shares $86,624.45 -10.9%3.2%3.4 $0.54 3/31/2023179,100 shares $103,878.00 +0.4%3.6%2.6 $0.58 3/15/2023178,400 shares $116,691.44 -8.8%3.9%0.4 $0.65 2/28/2023195,700 shares $144,818.00 +3.0%4.3%0.5 $0.74 2/15/2023190,000 shares $154,166.00 +17.4%4.1%0.5 $0.81 1/31/2023161,900 shares $148,948.00 -19.9%3.8%0.4 $0.92 1/15/2023202,100 shares $188,438.04 +1,041.8%4.0%0.5 $0.93 12/30/202217,700 shares $12,434.25 -0.6%0.4%0 $0.70 12/15/202217,800 shares $16,294.12 +18.7%0.4%1.1 $0.92 11/30/202215,000 shares $18,600.00 -36.2%0.3%1 $1.24 11/15/202223,500 shares $35,720.00 +142.3%0.5%1.9 $1.52 10/31/20229,700 shares $22,693.15 -80.1%0.2%1.2 $2.34 10/15/202248,800 shares $23,472.80 -22.3%0.2%1.9 $0.48 9/30/202262,800 shares $35,042.40 -34.9%0.3%2.5 $0.56 9/15/202296,500 shares $65,484.90 +20.6%0.4%3 $0.68 8/31/202280,000 shares $57,040.00 +0.3%0.3%2.2 $0.71 8/15/202279,800 shares $65,436.00 -31.9%0.3%0.9 $0.82 7/31/2022117,100 shares $99,535.00 -18.7%0.5%1.2 $0.85 7/15/2022144,100 shares $124,646.50 -35.7%0.6%1.5 $0.87 6/30/2022224,000 shares $203,840.00 -37.3%0.9%2.1 $0.91 6/15/2022357,200 shares $256,112.40 +95.9%1.4%0.7 $0.72 5/31/2022182,300 shares $129,013.71 +18.8%0.7%0.3 $0.71 5/15/2022153,400 shares $101,811.58 -8.1%0.6%0.3 $0.66 4/30/2022167,000 shares $161,939.90 -26.2%0.7%0.4 $0.97 4/15/2022226,200 shares $246,558.00 -40.7%0.9%0.5 $1.09 3/31/2022381,500 shares $545,545.00 +344.1%1.5%0.8 $1.43 3/15/202285,900 shares $85,900.00 -15.8%0.4%1.1 $1.00 2/28/2022102,000 shares $113,220.00 +8.3%0.4%1.1 $1.11 2/15/202294,200 shares $112,098.00 -6.3%0.4%0.9 $1.19 1/31/2022100,500 shares $102,510.00 -11.5%0.4%0.9 $1.02URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)My friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92% win rate trading system is built to profit in any market – whether Bitcoin is mooning, correcting, or chopping sideways. No more guessing. No more stress. Just precision trades that put you in control.>> See How In Their FREE Workshop 1/15/2022113,600 shares $139,728.00 -18.7%0.5%0.8 $1.23 12/31/2021139,700 shares $188,595.00 +71.8%0.6%1.1 $1.35 12/15/202181,300 shares $132,519.00 -3.7%0.3%0.7 $1.63 11/30/202184,400 shares $161,204.00 -17.8%0.4%0.8 $1.91 11/15/2021102,700 shares $230,048.00 +8.0%0.4%1 $2.24 10/29/202195,100 shares $213,975.00 -10.4%0.4%0.8 $2.25 10/15/2021106,100 shares $237,664.00 +5.4%0.4%1.1 $2.24 9/30/2021100,700 shares $234,631.00 -35.5%0.4%0.9 $2.33 9/15/2021156,200 shares $371,756.00 -4.8%0.6%1.1 $2.38 8/31/2021164,100 shares $431,583.00 -22.4%0.7%0.9 $2.63 8/13/2021211,500 shares $545,670.00 No Change0.9%0.9 $2.58 3/15/2021723,800 shares $3.50 million +46.5%8.6%0.3 $4.83 2/12/20211,150,000 shares $7.49 million +421.8%40.5%0.6 $6.51 1/29/2021220,400 shares $1.90 million +208.7%5.9%0.2 $8.60 1/15/202171,400 shares $342,720.00 -40.9%1.9%0.1 $4.80 12/31/202028,600 shares $94,380.00 +78.8%0.8%0.1 $3.30 12/15/202028,600 shares $97,812.00 +78.8%0.8%0.1 $3.42 11/30/202016,000 shares $43,200.00 +0.6%0.5%0 $2.70 11/15/202015,900 shares $41,181.00 -46.8%0.5%0.1 $2.59 10/30/202029,900 shares $67,873.00 -5.4%0.9%0 $2.27 10/15/202031,600 shares $115,656.00 +15.8%1.3%0 $3.66 9/30/202027,300 shares $120,393.00 -40.1%1.1%0 $4.41 9/15/202045,600 shares $174,192.00 -79.3%2.1%0 $3.82 8/31/2020220,700 shares $1.09 million +931.3%9.9%0.1 $4.96 8/14/202021,400 shares $123,050.00 +79.8%1.0%0 $5.75 7/31/202011,900 shares $34,629.00 -67.4%0.6%0.2 $2.91 7/15/202036,500 shares $108,040.00 +49.0%1.7%0.6 $2.96 6/30/202024,500 shares $74,235.00 +124.8%1.1%0.4 $3.03 6/15/202010,900 shares $31,610.00 +2,080.0%0.5%0.2 $2.90 5/29/2020500 shares $1,585.00 -82.1%0.0%0 $3.17 5/15/20202,800 shares $8,652.00 -71.1%0.2%0.1 $3.09 VYNT Short Interest - Frequently Asked Questions What is Vyant Bio's current short interest? Short interest is the volume of Vyant Bio shares that have been sold short but have not yet been closed out or covered. As of December 31st, investors have sold 42,600 shares of VYNT short. Learn More on Vyant Bio's current short interest. Is Vyant Bio's short interest increasing or decreasing? Vyant Bio saw a decline in short interest in the month of December. As of December 31st, there was short interest totaling 42,600 shares, a decline of 2.3% from the previous total of 43,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Vyant Bio's short interest compare to its competitors? Here is how the short interest of companies in the industry of "healthcare" compare to Vyant Bio: BioCorRx Inc. (0.04%), Vsee Health, Inc. (0.63%), Aclarion, Inc. (6.28%), Mitesco, Inc. (0.01%), ATI Physical Therapy, Inc. (5.31%), Ethema Health Co. (0.00%), NewGenIvf Group Limited (10.02%), First Choice Healthcare Solutions, Inc. (0.00%), IMAC Holdings, Inc. (2.16%), Genesis Healthcare, Inc. (0.01%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: General Motors ($4.15 billion), T-Mobile US, Inc. ($3.92 billion), TC Energy Co. ($3.66 billion), Charter Communications, Inc. ($3.35 billion), Coinbase Global, Inc. ($3.32 billion), Occidental Petroleum Co. ($2.91 billion), Tractor Supply ($2.80 billion), Rivian Automotive, Inc. ($2.44 billion), Moderna, Inc. ($2.41 billion), and United Rentals, Inc. ($2.23 billion). View all of the most shorted stocks. What does it mean to sell short Vyant Bio stock? Short selling VYNT is an investing strategy that aims to generate trading profit from Vyant Bio as its price is falling. VYNT shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Vyant Bio? A short squeeze for Vyant Bio occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VYNT, which in turn drives the price of the stock up even further. How often is Vyant Bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VYNT, twice per month. The most recent reporting period available is December, 31 2023. More Short Interest Resources from MarketBeat Related Companies BioCorRx Short Interest Vsee Health Short Interest Aclarion Short Interest Mitesco Short Interest ATI Physical Therapy Short Interest Ethema Health Short Interest NewGenIvf Group Short Interest First Choice Healthcare Solutions Short Interest IMAC Short Interest Genesis Healthcare Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:VYNT) was last updated on 5/9/2025 by MarketBeat.com Staff From Our PartnersElon Warns “America Is Broke”. Trump’s Plan Inside.Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vyant Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vyant Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VYNT Stock Free VYNT Stock Alerts